Interpace Diagnostics (IDXG) Reports Q1 EPS of $0.42
Tweet
Share
E-mailGet Alerts IDXG Hot Sheet
Join SI Premium – FREE
Interpace Diagnostics (NASDAQ: IDXG) reported Q1 EPS of $0.42, versus ($2.26) reported last year. Revenue for the quarter came in at $3.5 million, versus $3.04 million reported last year.
For earnings history and earnings-related data on Interpace Diagnostics (IDXG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras CEO says investors misunderstood margin guidance
- Qualcomm targets $40B in non-handset revenue by fiscal 2029
- JPMorgan and Goldman raise dividends after Fed stress tests
Create E-mail Alert Related Categories
Earnings, Momentum MoversRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
